108 related articles for article (PubMed ID: 12081325)
1. DNA and protein changes caused by disease in human breast tissues probed by the Kubelka-Munk spectral functional.
Yang Y; Celmer EJ; Koutcher JA; Alfano RR
Photochem Photobiol; 2002 Jun; 75(6):627-32. PubMed ID: 12081325
[TBL] [Abstract][Full Text] [Related]
2. UV reflectance spectroscopy probes DNA and protein changes in human breast tissues.
Yang Y; Celmer EJ; Koutcher JA; Alfano RR
J Clin Laser Med Surg; 2001 Feb; 19(1):35-9. PubMed ID: 11547817
[TBL] [Abstract][Full Text] [Related]
3. [Gastric cancer detection using kubelka-Munk spectral function of DNA and protein absorption bands].
Li LQ; Wei HJ; Guo ZY; Yang HQ; Xie SS; Chen XM; Li LB; He BH; Wu GY; Lu JJ
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Sep; 29(9):2499-504. PubMed ID: 19950661
[TBL] [Abstract][Full Text] [Related]
4. [Colon adenoma detection using Kubelka-Munk spectral function of DNA and protein bands].
Wei HJ; Guo ZY; Xie SS; He BH; Li LB; Chen XM; Wu GY; Lu JJ
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Jun; 29(6):1473-7. PubMed ID: 19810511
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of breast cancer using diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least squares analysis based feature extraction technique.
Zhu C; Palmer GM; Breslin TM; Harter J; Ramanujam N
Lasers Surg Med; 2006 Aug; 38(7):714-24. PubMed ID: 16799981
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
7. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
8. Cellular expression of growth hormone and prolactin receptors in human breast disorders.
Mertani HC; Garcia-Caballero T; Lambert A; Gérard F; Palayer C; Boutin JM; Vonderhaar BK; Waters MJ; Lobie PE; Morel G
Int J Cancer; 1998 Apr; 79(2):202-11. PubMed ID: 9583737
[TBL] [Abstract][Full Text] [Related]
9. [Methylation of Runx3 promoter in different breast lesions].
Wang X; Zheng X; Lin X; Shi Y; He Y; Chen G
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):447-50. PubMed ID: 25327792
[TBL] [Abstract][Full Text] [Related]
10. Expression of hyaluronan in benign and malignant breast lesions.
Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
[TBL] [Abstract][Full Text] [Related]
11. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.
Dugimont T; Curgy JJ; Wernert N; Delobelle A; Raes MB; Joubel A; Stehelin D; Coll J
Biol Cell; 1995; 85(2-3):117-24. PubMed ID: 8785513
[TBL] [Abstract][Full Text] [Related]
12. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues.
Sóñora C; Mazal D; Berois N; Buisine MP; Ubillos L; Varangot M; Barrios E; Carzoglio J; Aubert JP; Osinaga E
J Histochem Cytochem; 2006 Mar; 54(3):289-99. PubMed ID: 16148312
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
[TBL] [Abstract][Full Text] [Related]
15. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and ultrastructural correlations of calreticulin and thioredoxin expression in breast mucinous carcinoma and infiltrating ductal carcinoma non-special type.
Baltatzis GE; Gaitanarou H; Arnogianaki N; Misitzis J; Voloudakis-Baltatzis IE
Ultrastruct Pathol; 2011 Feb; 35(1):7-13. PubMed ID: 20929309
[TBL] [Abstract][Full Text] [Related]
17. TPS cytosolic levels in non-malignant breast diseases.
Alvarez A; Martinez Rodriguez PI; Nuñez MI; Alba A; Allende MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):183-5. PubMed ID: 8551064
[No Abstract] [Full Text] [Related]
18. Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma.
Patel NA; Patel PS; Vora HH
Breast Dis; 2015; 35(2):113-27. PubMed ID: 25547164
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Kubelka-Munk reflectance theory applied to human dentin and enamel.
Ragain JC; Johnston WM
J Dent Res; 2001 Feb; 80(2):449-52. PubMed ID: 11332530
[TBL] [Abstract][Full Text] [Related]
20. Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast.
Bock N; Meden H; Regenbrecht M; Jünemann B; Wangerin J; Marx D
Anticancer Res; 2000; 20(1A):119-24. PubMed ID: 10769643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
